In the U.S., drug prices are shaped by complex negotiations involving pharmacy benefit managers that act as middlemen between drugmakers and employer clients and health insurers and have been criticised for inflating costs. In Europe, countries generally have public health systems that negotiate directly with manufacturers and keep costs down.
/…/
Trump said if drugmakers do not cut prices they could be hit with tariffs.
Pharmaceutical companies will demand higher prices from countries with socialized healthcare. Those higher costs will be passed on to the citizens of those countries. Those citizens will get angry(ier) at the US. US citizens will see little to no cost reduction in drug prices, but any, no matter how minor, will be touted as a victory by Team Trump. And none of them will ever recognize why countries with socialized healthcare can negotiate lower drug costs.
The end result is the US becomes even more isolated and hated by the world.
deleted by creator